North Star Investment Management Corp. Purchases 1515 Shares of Metlife Inc (MET)

North Star Investment Management Corp.'s holdings in Metlife were worth $819,000 as of its most recent SEC filing.

It also reduced Cdn Imperial Bk Comm Toronto (NYSE:CM) stake by 7,435 shares and now owns 107,698 shares. Bronfman E.L. Rothschild L.P. increased its holdings in shares of Metlife by 0.7% during the 2nd quarter. Epoch Investment Partners Inc. now owns 10,291,110 shares of the financial services provider's stock valued at $534,623,000 after acquiring an additional 6,954,917 shares during the last quarter. Aspen Investment Management Inc increased its holdings in Metlife by 0.7% in the 2nd quarter. Sumitomo Life Insurance Co. now owns 38,716 shares of the financial services provider's stock worth $2,127,000 after purchasing an additional 1,631 shares during the period. Livforsakringsbolaget Skandia Omsesidigt increased its position in MetLife by 116.9% in the third quarter. Richard Bernstein Advisors LLC now owns 108,215 shares of the company's stock worth $4,808,000 after buying an additional 55,670 shares in the last quarter. Epoch Investment Partners Inc. grew its position in Metlife by 208.5% during the third quarter. Patriot Financial Group Insurance Agency LLC now owns 11,135 shares of the financial services provider's stock worth $624,000 after acquiring an additional 216 shares in the last quarter. MetLife, Inc. (NYSE:MET) has risen 13.92% since January 13, 2017 and is uptrending. Metlife Inc has a twelve month low of $44.26 and a twelve month high of $55.91. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.31. The stock has a market cap of $56,120.00, a PE ratio of 115.93, a PEG ratio of 1.21 and a beta of 1.49.

Metlife (NYSE:MET) last issued its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.19. MetLife had a net margin of 1.30% and a return on equity of 7.17%. The business had revenue of $16.10 billion for the quarter, compared to analysts' expectations of $15.47 billion. During the same quarter in the previous year, the company posted $1.28 EPS. During the same quarter in the previous year, the business posted $1.28 earnings per share. equities analysts predict that Metlife will post 4.4 EPS for the current year. Shareholders of record on Monday, February 5th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 annualized dividend and a dividend yield of 3.04%. Metlife's payout ratio is now 347.83%. It dropped, as 61 investors sold MET shares while 336 reduced holdings. ValuEngine cut shares of Metlife from a "strong-buy" rating to a "buy" rating in a report on Tuesday, October 10th. Jefferies maintained the stock with "Buy" rating in Monday, April 24 report. They noted that the move was a valuation call. FBR & Co restated a "buy" rating and set a $53.00 target price on shares of Metlife in a report on Tuesday, August 29th. TheStreet raised shares of Metlife from a "c+" rating to a "b" rating in a report on Wednesday, October 4th. Out of 2 Wall Street analysts rating Allstate, 1 give it "Buy", 0 "Sell" rating, while 1 recommend "Hold". Metlife now has an average rating of "Hold" and a consensus target price of $57.90. Also, insider Christopher G. Townsend sold 82,731 shares of the firm's stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $56.18, for a total transaction of $842,531.46. Moreover, Saba Capital Management L.P. has 0.25% invested in the company for 200,716 shares. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christopher G. Townsend sold 55,712 shares of the business's stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the completion of the sale, the executive vice president now directly owns 70,560 shares in the company, valued at approximately $3,964,060.80. The disclosure for this sale can be found here. Klingenstein Fields And Ltd Limited Liability Company owns 410,352 shares or 0.82% of their U.S. portfolio.

Daimler (DAI) Given a €68.00 Price Target by Morgan Stanley Analysts
Barclays reiterated their neutral rating on shares of Daimler (ETR:DAI) in a research report report published on Thursday morning. Kepler Capital Markets reissued a buy rating on shares of Daimler AG in a report on Thursday, October 6th.

WARNING: "Zacks Investment Research Lowers Metlife (MET) to Hold" was originally posted by TrueBlueTribune and is the property of of TrueBlueTribune. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and worldwide trademark & copyright law.

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company's segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).

Noticias recomendadas

Nos complace brindar esta oportunidad para compartir información, experiencias y observaciones sobre lo que está en las noticias.
Algunos de los comentarios se pueden reimprimir en otras partes del sitio o en el periódico.
Gracias por tomarse el tiempo para ofrecer sus pensamientos.